COVID-19-driven drop in cancer screenings didn’t lead to spike in cases, Epic finds

After scouring more than 373,000 diagnoses in EHRs, researchers at Epic found that the COVID-19-induced drop in cancer screenings did not lead to a significant spike in breast, cervical or colon cancer cases.

Advertisement

The research showed a clear drop in cancer diagnoses, accordant with screenings, at the beginning of the COVID-19 pandemic. 

But as screening rates returned to normal, so did cancer diagnoses, according to a study published Feb. 17 in Epic Research.

The findings could calm fears of missed cancer cases caused by the pandemic. However, the researchers warned that while their data does not show an increase in advanced cancers, it could take years to get a clearer picture. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in EHRs / Interoperability

Advertisement

Comments are closed.